Logo

CapitalBio Signs up Mexican Distributor

Jun 16, 2009

NEW YORK (GenomeWeb News) – CapitalBio has signed up the Mexican medical and lab research equipment provider Accessolab to distribute its product line in Mexico, Beijing-based CapitalBio said today.

The distribution agreement covers CapitalBio's biochip microarray technologies, reagents, and related services.

CapitalBio CEO Jing Cheng said in a statement that Accessolab's client base of research labs, clinicians, and those in the life sciences "fit well with our range of products."

Filed under

Microarrays & Multiplexing
microarrays
CapitalBio
Breaking News
The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.